Long-term follow-up of patients treated with caplacizumab and safety and efficacy of repeat caplacizumab use: Post-HERCULES study.
Marie Anne ScullyJavier de la RubiaKaterina PavenskiAra MetjianPaul N KnöblFlora PeyvandiSpero R CatalandPaul CoppoJohanna A Kremer HovingaJessica Minkue Mi EdouRui de Passos SousaFilip CallewaertSriya GunawardenaJulie LinPublished in: Journal of thrombosis and haemostasis : JTH (2022)
Long-term follow-up supports the safety and efficacy of caplacizumab for iTTP and its repeated use for recurrences.
Keyphrases